Novartis coasts towards first CAR-T cancer treatment approval – Chemistry World (subscription)
|
Novartis coasts towards first CAR–T cancer treatment approval
Chemistry World (subscription) The first cancer therapy based on the revolutionary CAR–T approach, which genetically reprograms patients' own white blood cells, looks set for approval in early October. On 12 July, a 10-person US Food and Drug Administration (FDA) committee … |
